EPAS1 and anemia: In summary, the present data indicated that ASP enhanced both renal and hepatic EPO production via stabilizing HIF-2α protein and attenuating inflammatory suppression, restored EPOR signaling systems, and increased iron availability by suppressing hepcidin and inflammation, thereby correcting anemia in CKD rats (Figure 9).